NCT01515137 Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma Status COMPLETED Phase PHASE1
NCT01484847 A Study of PF-00299804 When Given Through a Feeding Tube in Locally Advanced Head and Neck Squamous Cell Carcinoma Status COMPLETED Phase NA
NCT01469546 Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck Cancer Status COMPLETED Phase PHASE2
NCT01427478 Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE3
NCT01425736 Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma Status COMPLETED Phase PHASE2
NCT01377298 Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Status UNKNOWN Phase PHASE2
NCT01280318 Profile of Plasma Growth Factors Before and After Head and Neck Oncological or Non-oncological Surgery Status COMPLETED Phase PHASE1/PHASE2
NCT01172769 Efficacy Study of Temsirolimus to Treat Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT01154920 Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01086826 Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE3
NCT01045421 Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT00894413 A Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract Status COMPLETED Phase PHASE2
NCT00805012 Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC) Status TERMINATED Phase PHASE2
NCT00765791 2B or Not 2B? Shoulder Function After Level 2B Neck Dissection: A Randomized Controlled Study Status COMPLETED Phase NA
NCT00634777 Assessment of Regional Response With PET-FDG in Advanced Head and Neck Squamous Cell Carcinoma Status UNKNOWN Phase NA
NCT00620139 Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma Status COMPLETED Phase N/A